“ Intestinal Microsporidiosis: A Hidden Risk in Rheumatic Disease Patients Undergoing Anti-Tumor Necrosis Factor Therapy Combined With Disease-Modifying Anti-Rheumatic Drugs? ”. Clinics, vol. 66, no. 7, Jan. 2011, pp. 1171-5, https://doi.org/10.1590/S1807-59322011000700008.